SEB Concept Biotechnology D/  LU0118405827  /

Fonds
NAV2024-04-24 Chg.-0.5640 Type of yield Investment Focus Investment company
105.3740EUR -0.53% paying dividend Equity Worldwide SEB IM 

Investment strategy

The fund aims to increase the value of your investment over time and to outperform its benchmark. The fund is actively managed and invests in stocks globally, primarily in the biotech sector. Investment decisions are based on in-depth (fundamental) analysis. The focus is on companies' business models, earning capacity, management and market positions. The return is determined by how much the fund's holdings increase or decrease in value during your holding period.
 

Investment goal

The fund aims to increase the value of your investment over time and to outperform its benchmark.
 

Master data

Type of yield: paying dividend
Funds Category: Equity
Region: Worldwide
Branch: Sector Biotechnology
Benchmark: Nasdaq Biotechnology Index
Business year start: 01-01
Last Distribution: 2023-05-25
Depository bank: Skandinaviska Enskilda Banken AB, Lux
Fund domicile: Luxembourg
Distribution permission: Germany
Fund manager: Angelica Fatouros
Fund volume: 136.5 mill.  EUR
Launch date: 2000-10-16
Investment focus: -

Conditions

Issue surcharge: 0.00%
Max. Administration Fee: 1.50%
Minimum investment: - EUR
Deposit fees: -
Redemption charge: 0.00%
Key Investor Information: Download (Print version)
 

Investment company

Funds company: SEB IM
Address: Stephanstraße 14 - 16, 60313, Frankfurt am Main
Country: Germany
Internet: seb.de/asset-management
 

Assets

Stocks
 
96.84%
Cash
 
3.14%
Others
 
0.02%

Countries

United States of America
 
76.87%
United Kingdom
 
6.97%
Sweden
 
3.47%
Cash
 
3.14%
Denmark
 
2.27%
Netherlands
 
2.19%
Ireland
 
2.05%
Bermuda
 
1.34%
Canada
 
1.11%
Cayman Islands
 
0.30%
Others
 
0.29%

Branches

Pharma/Biotechnology
 
90.10%
Healthcare services
 
4.15%
Cash
 
3.14%
Healthcare appliances
 
2.33%
Others
 
0.28%